Valkleidson Santos de Araújo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Valkleidson Santos de Araújo has a total of 46 co-authors. Here are the top co-authors by number of shared publications:
- Aurigena Antunes de Araújo
Department of Biophysics and Pharmacology, Biosciences Center, Federal University of Rio Grande do Norte, Natal 59072-970, Natal, Brazil
4 shared publications - Maria Luiza Diniz de Sousa Lopes
Universidade Federal do Rio Grande do Norte, Brasil
4 shared publications - Agnes Andrade Martins
Department of Dentistry , Federal University of Rio Grande Norte , Natal , Rio Grande do Norte , Brazil
3 shared publications - Davi Neto de Araújo Silva
Section of Periodontics School of Dentistry University of California Los Angeles California USA
3 shared publications - Flavia Queiroz Pirih
Section of Periodontics, School of Dentistry, University of California, Los Angeles, CA, USA
3 shared publications - José Sandro Pereira da Silva
Universidade Federal do Rio Grande do Norte, Brazil
3 shared publications
Latest Publications
- Open Access
- 1 January 2026
- Published by Wiley in BioMed Research International
- Vol. 2026 (1) , 8065442
Physicochemical Characterization, Cytotoxicity, and In Vivo Evaluation of a Hydroxyapatite–Silver Composite for Bone Regeneration
This study is aimed at characterizing the physicochemical and biological properties of a hydroxyapatite–silver (HAp‐Ag) composite for bone regeneration. HAp and HAp‐Ag powders were analyzed using field emission scanning electron microscopy, energy‐dispersive X‐ray spectroscopy, X‐ray diffraction and fluorescence, and Fourier transform infrared spectroscopy. Cylindrical pellets obtained by powder pressing and sintering were evaluated for fracture toughness, compressive strength, relative density, porosity, and wettability. Cell viability was assessed using the Alamar Blue assay. In the in vivo experiment, an 8‐mm critical‐size calvarial defect was surgically created in 36 male Wistar rats randomly divided into three groups: control group (CG), untreated defect; HAp group, defect filled with HAp pellet; and HAp‐Ag group, defect filled with HAp‐Ag pellet. Euthanasia was performed after 90 days, and calvaria samples were analyzed by μ ‐CT, histology, cytokine quantification, and gene expression analysis. The powders showed an irregular, agglomerated morphology, with HAp elements and silver detected in the HAp‐Ag sample. Incorporation of Ag into HAp increased fracture toughness (0.66–0.94 MPa.m 1/2 ) and porosity (16.43%–25.95%) and reduced compressive strength (43.17–23.99 MPa) and contact angle (36.32°–10.51°). MC3T3‐E1 preosteoblastic cell viability was higher on HAp‐Ag surface compared to HAp pellets at Days 1 and 7. Compared to CG, defects filled with biomaterials showed greater bone formation and better bone quality parameters. In addition, a more advanced stage of bone maturation was observed in the animals treated with HAp‐Ag. HAp‐Ag composite upregulated TNF‐ α and IL‐1 β levels and Procollagen 3 and eNOS gene expression compared to CG. Silver incorporation into HAp increased fracture toughness and porosity, reduced compressive strength, and improved wettability. Despite these changes, HAp‐Ag enhanced cell viability and in vivo bone maturation, indicating that Ag addition does not compromise and may improve its bone regeneration potential.
- 1 January 2026
- Published by Wiley in BioMed Research International
- Vol. 2026 (1) , 8065442
Open AccessPhysicochemical Characterization, Cytotoxicity, and In Vivo Evaluation of a Hydroxyapatite–Silver Composite for Bone Regeneration
This study is aimed at characterizing the physicochemical and biological properties of a hydroxyapatite–silver (HAp‐Ag) composite for bone regeneration. HAp and HAp‐Ag powders were analyzed using field emission scanning electron microscopy, energy‐dispersive X‐ray spectroscopy, X‐ray diffraction and fluorescence, and Fourier transform infrared spectroscopy. Cylindrical pellets obtained by powder pressing and sintering were evaluated for fracture toughness, compressive strength, relative density, porosity, and wettability. Cell viability was assessed using the Alamar Blue assay. In the in vivo experiment, an 8‐mm critical‐size calvarial defect was surgically created in 36 male Wistar rats randomly divided into three groups: control group (CG), untreated defect; HAp group, defect filled with HAp pellet; and HAp‐Ag group, defect filled with HAp‐Ag pellet. Euthanasia was performed after 90 days, and calvaria samples were analyzed by μ ‐CT, histology, cytokine quantification, and gene expression analysis. The powders showed an irregular, agglomerated morphology, with HAp elements and silver detected in the HAp‐Ag sample. Incorporation of Ag into HAp increased fracture toughness (0.66–0.94 MPa.m 1/2 ) and porosity (16.43%–25.95%) and reduced compressive strength (43.17–23.99 MPa) and contact angle (36.32°–10.51°). MC3T3‐E1 preosteoblastic cell viability was higher on HAp‐Ag surface compared to HAp pellets at Days 1 and 7. Compared to CG, defects filled with biomaterials showed greater bone formation and better bone quality parameters. In addition, a more advanced stage of bone maturation was observed in the animals treated with HAp‐Ag. HAp‐Ag composite upregulated TNF‐ α and IL‐1 β levels and Procollagen 3 and eNOS gene expression compared to CG. Silver incorporation into HAp increased fracture toughness and porosity, reduced compressive strength, and improved wettability. Despite these changes, HAp‐Ag enhanced cell viability and in vivo bone maturation, indicating that Ag addition does not compromise and may improve its bone regeneration potential.
- Open Access
- 1 January 2026
- Published by Wiley in BioMed Research International
- Vol. 2026 (1) , e6614534
Comparative Biocompatibility of Portland‐Based Endodontic Cements Containing Niobium and/or Bismuth Oxides in Rat Subcutaneous Tissue
Objectives: To evaluate the in vitro cytocompatibility and osteogenic potential and the in vivo biocompatibility of two experimental endodontic cements based on Portland cement combined with either Nb2O 5 (F6) and/or bismuth oxide (F7) in a rat subcutaneous implantation model. Methods: For the in vitro study, MC3T3‐E1 preosteoblastic cells were exposed to MTA Angelus, F6, or F7, and cell viability was assessed at 24 and 48 h using the Alamar Blue assay. Osteogenic differentiation was evaluated by alkaline phosphatase (ALP) activity after 14 days. For the in vivo analysis, polyethylene tubes containing the materials were implanted into the dorsal subcutaneous tissue of rats and evaluated at 7, 14, and 30 days, with empty tubes used as controls. Histological and histochemical analyses included hematoxylin and eosin (H&E), Picrosirius Red, Von Kossa staining, and TNF‐ α immunohistochemistry. Chemical characterization was performed using Raman spectroscopy and X‐ray fluorescence (XRF). In vitro data were analyzed using one‐way ANOVA followed by Tukey’s post hoc test, while semiquantitative histological data were analyzed using the Kruskal–Wallis test followed by Dunn’s test. A significance level of 5% ( p < 0.05) was adopted. Results: In vitro, F6 showed cell viability comparable to MTA Angelus at both 24 h (36.22 ± 2.66 % vs. 35.75 ± 1.18 % ) and 48 h (34.18 ± 3.09 % vs. 35.20 ± 2.35 % ) ( p > 0.05). In contrast, F7 significantly reduced cell viability at 24 h (25.61 ± 1.11 % ) compared with MTA Angelus ( p = 0.002), although no difference was observed at 48 h ( p > 0.05). ALP activity after 14 days did not differ significantly among MTA Angelus (1.90 ± 1.23 UI/L/g), F6 (1.71 ± 0.88 UI/L/g), and F7 (1.78 ± 1.34 UI/L/g) ( p = 0.703). In vivo, F6 induced mild to moderate inflammatory responses at the early time period, with a significant reduction by Day 14 and minimal inflammation at Day 30, comparable to MTA Angelus. No multinucleated giant cells were observed, and TNF‐ α expression was moderate. Von Kossa staining and XRF confirmed calcium deposition, while Raman spectroscopy detected niobium species in peri‐implant tissues, indicating bioactivity. Picrosirius Red staining demonstrated progressive collagen fiber organization. Conversely, F7 elicited a pronounced and persistent inflammatory response characterized by multinucleated giant cells, intense TNF‐ α expression, and bismuth retention in surrounding tissues, as confirmed by XRF, with no niobium‐related signals detected by Raman analysis. Conclusion: The niobium‐containing cement (F6) demonstrated favorable in vitro cytocompatibility and in vivo biocompatibility.
- 1 January 2026
- Published by Wiley in BioMed Research International
- Vol. 2026 (1) , e6614534
Open AccessComparative Biocompatibility of Portland‐Based Endodontic Cements Containing Niobium and/or Bismuth Oxides in Rat Subcutaneous Tissue
Objectives: To evaluate the in vitro cytocompatibility and osteogenic potential and the in vivo biocompatibility of two experimental endodontic cements based on Portland cement combined with either Nb2O 5 (F6) and/or bismuth oxide (F7) in a rat subcutaneous implantation model. Methods: For the in vitro study, MC3T3‐E1 preosteoblastic cells were exposed to MTA Angelus, F6, or F7, and cell viability was assessed at 24 and 48 h using the Alamar Blue assay. Osteogenic differentiation was evaluated by alkaline phosphatase (ALP) activity after 14 days. For the in vivo analysis, polyethylene tubes containing the materials were implanted into the dorsal subcutaneous tissue of rats and evaluated at 7, 14, and 30 days, with empty tubes used as controls. Histological and histochemical analyses included hematoxylin and eosin (H&E), Picrosirius Red, Von Kossa staining, and TNF‐ α immunohistochemistry. Chemical characterization was performed using Raman spectroscopy and X‐ray fluorescence (XRF). In vitro data were analyzed using one‐way ANOVA followed by Tukey’s post hoc test, while semiquantitative histological data were analyzed using the Kruskal–Wallis test followed by Dunn’s test. A significance level of 5% ( p < 0.05) was adopted. Results: In vitro, F6 showed cell viability comparable to MTA Angelus at both 24 h (36.22 ± 2.66 % vs. 35.75 ± 1.18 % ) and 48 h (34.18 ± 3.09 % vs. 35.20 ± 2.35 % ) ( p > 0.05). In contrast, F7 significantly reduced cell viability at 24 h (25.61 ± 1.11 % ) compared with MTA Angelus ( p = 0.002), although no difference was observed at 48 h ( p > 0.05). ALP activity after 14 days did not differ significantly among MTA Angelus (1.90 ± 1.23 UI/L/g), F6 (1.71 ± 0.88 UI/L/g), and F7 (1.78 ± 1.34 UI/L/g) ( p = 0.703). In vivo, F6 induced mild to moderate inflammatory responses at the early time period, with a significant reduction by Day 14 and minimal inflammation at Day 30, comparable to MTA Angelus. No multinucleated giant cells were observed, and TNF‐ α expression was moderate. Von Kossa staining and XRF confirmed calcium deposition, while Raman spectroscopy detected niobium species in peri‐implant tissues, indicating bioactivity. Picrosirius Red staining demonstrated progressive collagen fiber organization. Conversely, F7 elicited a pronounced and persistent inflammatory response characterized by multinucleated giant cells, intense TNF‐ α expression, and bismuth retention in surrounding tissues, as confirmed by XRF, with no niobium‐related signals detected by Raman analysis. Conclusion: The niobium‐containing cement (F6) demonstrated favorable in vitro cytocompatibility and in vivo biocompatibility.
- Open Access
- 1 January 2024
- Published by FapUNIFESP (SciELO) in Brazilian Archives of Biology and Technology
- Vol. 67, e24240152
Niobium/Hydroxyapatite Composite as a Potential Stimulator of Bone Formation in Critical Size Calvarial Defects in Rats
This study aimed to analyze the physical features and effect of hydroxyapatite (HAp) and Niobium/HAp CaNb2O6/Ca3(PO4)2 composite on critical size defect in rat calvaria. Biomaterials were characterized by X-ray diffraction (XRD), X-ray fluorescence (XRF), Particle size distribution (PSD) and Scanning Electron Microscopy (SEM). Critical size (8 mm) calvarial defects were created in Wistar rats (n = 24) distributed in three groups (90 days): Control group (CG): critical defect no treatment; HAp group: Hydroxyapatite; CNb/CPO group: CaNb2O6/Ca3(PO4)2 composite. After 90 days, calvaria samples were subjected to histological, and immunohistochemical reactions for osteopontin and osteocalcin, and Micro-CT analyses. XRD analysis confirmed the formation of a crystalline structure of CNb/CPO. XRF measurements confirmed the presence of Nb added in the sample CNb/CPO. Fracture toughness from CNb/CPO composite was 0.82 MPa.m1/2. Micro-CT showed increased trabecular number (p˂0.001), decreased porosities (%) (p˂0.001) and decreased trabecular separation (mm) (p˂0.001) in the CNb/CPO compared to CG group. In CNb/CPO group showed presence of new bone in which connective tissue differentiates to form or indicate a bone matrix score 3 (3-3.75, p˂0.05) and strong immunoexpression of osteopontin (p<0.05). The findings indicate that CNb/CPO showed resistance to the propagation of cracks and stimulated bone formation in calvaria defects in rats.
- 1 January 2024
- Published by FapUNIFESP (SciELO) in Brazilian Archives of Biology and Technology
- Vol. 67, e24240152
Open AccessNiobium/Hydroxyapatite Composite as a Potential Stimulator of Bone Formation in Critical Size Calvarial Defects in Rats
This study aimed to analyze the physical features and effect of hydroxyapatite (HAp) and Niobium/HAp CaNb2O6/Ca3(PO4)2 composite on critical size defect in rat calvaria. Biomaterials were characterized by X-ray diffraction (XRD), X-ray fluorescence (XRF), Particle size distribution (PSD) and Scanning Electron Microscopy (SEM). Critical size (8 mm) calvarial defects were created in Wistar rats (n = 24) distributed in three groups (90 days): Control group (CG): critical defect no treatment; HAp group: Hydroxyapatite; CNb/CPO group: CaNb2O6/Ca3(PO4)2 composite. After 90 days, calvaria samples were subjected to histological, and immunohistochemical reactions for osteopontin and osteocalcin, and Micro-CT analyses. XRD analysis confirmed the formation of a crystalline structure of CNb/CPO. XRF measurements confirmed the presence of Nb added in the sample CNb/CPO. Fracture toughness from CNb/CPO composite was 0.82 MPa.m1/2. Micro-CT showed increased trabecular number (p˂0.001), decreased porosities (%) (p˂0.001) and decreased trabecular separation (mm) (p˂0.001) in the CNb/CPO compared to CG group. In CNb/CPO group showed presence of new bone in which connective tissue differentiates to form or indicate a bone matrix score 3 (3-3.75, p˂0.05) and strong immunoexpression of osteopontin (p<0.05). The findings indicate that CNb/CPO showed resistance to the propagation of cracks and stimulated bone formation in calvaria defects in rats.
- Open Access
- 1 January 2024
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Medical and Biological Research
- Vol. 57, e13913
Selective inhibition of interleukin 6 receptor decreased inflammatory cytokines and increased proteases in an experimental model of critical calvarial defect
Considering the lack of consensus related to the impact of selective IL-6 receptor inhibition on bone remodeling and the scarcity of reports, especially on large bone defects, this study proposed to evaluate the biological impact of the selective inhibitor of interleukin-6 receptor (tocilizumab) in an experimental model of critical calvarial defect in rats. In this preclinical and in vivo study, 24 male Wistar rats were randomly divided into two groups (n=12/group): defect treated with collagen sponge (CG) and defect treated with collagen sponge associated with 2 mg/kg tocilizumab (TCZ). The defect in the parietal bone was created using an 8-mm diameter trephine drill. After 90 days, the animals were euthanized, and tissue samples (skull caps) were evaluated through micro-CT, histological, immunohistochemistry, cytokines, and RT-qPCR analyses. Tocilizumab reduced mononuclear inflammatory infiltration (P0.05). Tocilizumab reduced inflammatory cytokines, decreased osteogenic protein, and increased proteases in a critical bone defect in rats. Ninety days after the local application of tocilizumab in the cranial defect, we did not find a significant formation of bone tissue compared with a collagen sponge.
- 1 January 2024
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Medical and Biological Research
- Vol. 57, e13913
Open AccessSelective inhibition of interleukin 6 receptor decreased inflammatory cytokines and increased proteases in an experimental model of critical calvarial defect
Considering the lack of consensus related to the impact of selective IL-6 receptor inhibition on bone remodeling and the scarcity of reports, especially on large bone defects, this study proposed to evaluate the biological impact of the selective inhibitor of interleukin-6 receptor (tocilizumab) in an experimental model of critical calvarial defect in rats. In this preclinical and in vivo study, 24 male Wistar rats were randomly divided into two groups (n=12/group): defect treated with collagen sponge (CG) and defect treated with collagen sponge associated with 2 mg/kg tocilizumab (TCZ). The defect in the parietal bone was created using an 8-mm diameter trephine drill. After 90 days, the animals were euthanized, and tissue samples (skull caps) were evaluated through micro-CT, histological, immunohistochemistry, cytokines, and RT-qPCR analyses. Tocilizumab reduced mononuclear inflammatory infiltration (P0.05). Tocilizumab reduced inflammatory cytokines, decreased osteogenic protein, and increased proteases in a critical bone defect in rats. Ninety days after the local application of tocilizumab in the cranial defect, we did not find a significant formation of bone tissue compared with a collagen sponge.
- 19 July 2023
- Published by Oxford University Press (OUP) in European Journal of Orthodontics
- Vol. 45 (6) , 747-763
Impact of orthognathic surgery on voice and speech: a systematic review and meta-analysis
Summary: Background: Orthognathic surgical procedures, whether in one or both jaws, can affect structures regarding the articulation and resonance of voice and speech. Objective: Evaluating the impact of orthognathic surgery on voice and speech performance in individuals with skeletal dentofacial disharmony. Search methods: Word combinations and truncations were adapted for the following electronic databases: EMBASE, PubMed/Medline, Scopus, Web of Science, Cochrane Library, and Latin American and Caribbean Literature in Health Sciences (LILACS), and grey literature. Selection criteria: The research included studies on nonsyndromic adults with skeletal dentofacial disharmony undergoing orthognathic surgery. These studies assessed patients before and after surgery or compared them with individuals with good facial harmony using voice and speech parameters through validated protocols. Data collection and analysis: Two independent reviewers performed all stages of the review. The Joanna Briggs Institute tool was used to assess risk of bias in the cohort studies, and ROBINS-I was used for nonrandomized clinical trials. The authors also performed a meta-analysis of random effects. Results: A total of 1163 articles were retrieved after the last search, of which 23 were read in full. Of these, four were excluded, totalling 19 articles for quantitative synthesis. When comparing the pre- and postoperative periods, both for fundamental frequency, formants, and jitter and shimmer perturbation measures, orthognathic surgery did not affect vowel production. According to the articles, the main articulatory errors associated with skeletal dentofacial disharmonies prior to surgery were distortions of fricative sounds, mainly/s/ and/z/. Conclusions: Orthognathic surgery may have little or no impact on vocal characteristics during vowel production. However, due to the confounding factors involved, estimates are inconclusive. The most prevalent articulatory disorders in the preoperative period were distortion of the fricative phonemes/s/ and/z/. However, further studies must be carried out to ensure greater robustness to these findings. Registration: PROSPERO (CRD42022291113)
- 19 July 2023
- Published by Oxford University Press (OUP) in European Journal of Orthodontics
- Vol. 45 (6) , 747-763
Impact of orthognathic surgery on voice and speech: a systematic review and meta-analysis
Summary: Background: Orthognathic surgical procedures, whether in one or both jaws, can affect structures regarding the articulation and resonance of voice and speech. Objective: Evaluating the impact of orthognathic surgery on voice and speech performance in individuals with skeletal dentofacial disharmony. Search methods: Word combinations and truncations were adapted for the following electronic databases: EMBASE, PubMed/Medline, Scopus, Web of Science, Cochrane Library, and Latin American and Caribbean Literature in Health Sciences (LILACS), and grey literature. Selection criteria: The research included studies on nonsyndromic adults with skeletal dentofacial disharmony undergoing orthognathic surgery. These studies assessed patients before and after surgery or compared them with individuals with good facial harmony using voice and speech parameters through validated protocols. Data collection and analysis: Two independent reviewers performed all stages of the review. The Joanna Briggs Institute tool was used to assess risk of bias in the cohort studies, and ROBINS-I was used for nonrandomized clinical trials. The authors also performed a meta-analysis of random effects. Results: A total of 1163 articles were retrieved after the last search, of which 23 were read in full. Of these, four were excluded, totalling 19 articles for quantitative synthesis. When comparing the pre- and postoperative periods, both for fundamental frequency, formants, and jitter and shimmer perturbation measures, orthognathic surgery did not affect vowel production. According to the articles, the main articulatory errors associated with skeletal dentofacial disharmonies prior to surgery were distortions of fricative sounds, mainly/s/ and/z/. Conclusions: Orthognathic surgery may have little or no impact on vocal characteristics during vowel production. However, due to the confounding factors involved, estimates are inconclusive. The most prevalent articulatory disorders in the preoperative period were distortion of the fricative phonemes/s/ and/z/. However, further studies must be carried out to ensure greater robustness to these findings. Registration: PROSPERO (CRD42022291113)
- Open Access
- 13 May 2022
- Published by Research, Society and Development in Research, Society and Development
- Vol. 11 (7)
Atividade antibacteriana de imburana-de-espinho sobre bactérias do meio ambiente bucal
Due to the high rates of oral infections, in parallel with the need for new antimicrobial methods, herbal medicines have been the choice with effective action and less toxicity, when vigorously standardized. The medicinal plant Commiphora leptophloeos (Mart.) JB Gillett, popularly known as imburana-de-espinho, found in the Caatinga biome, has been researched for this purpose. Thus, the objective of the research is to investigate in vitro the antimicrobial, bactericidal and anti-adherent action of the hydroethanolic extract of the stem bark of Commiphora leptophloeos (Mart.) J.B. Gillett on Streptococcus mutans. After making the extract, 3 experiments were carried out: determination of the minimum inhibitory concentration (MIC) of the extract from the stem bark of C. leptophloeos; determination of adhesion minimum inhibitory concentration (MICA) and; determination of bactericidal kinetics (BC) with S. mutans culture. The result for the MIC was the 1:16 dilution (3,125 x 10-2 g/mL), while the CIMA was the 1:128 dilution (3,90625 x 10-3 g/mL) and CB showed bacterial growth 2 hours after the contact of the extract with the bacteria. The conclusion of the present study is that the extract has bacteriostatic and anti-adherent action, however, the bactericidal kinetics needs further studies.
- 13 May 2022
- Published by Research, Society and Development in Research, Society and Development
- Vol. 11 (7)
Open AccessAtividade antibacteriana de imburana-de-espinho sobre bactérias do meio ambiente bucal
Due to the high rates of oral infections, in parallel with the need for new antimicrobial methods, herbal medicines have been the choice with effective action and less toxicity, when vigorously standardized. The medicinal plant Commiphora leptophloeos (Mart.) JB Gillett, popularly known as imburana-de-espinho, found in the Caatinga biome, has been researched for this purpose. Thus, the objective of the research is to investigate in vitro the antimicrobial, bactericidal and anti-adherent action of the hydroethanolic extract of the stem bark of Commiphora leptophloeos (Mart.) J.B. Gillett on Streptococcus mutans. After making the extract, 3 experiments were carried out: determination of the minimum inhibitory concentration (MIC) of the extract from the stem bark of C. leptophloeos; determination of adhesion minimum inhibitory concentration (MICA) and; determination of bactericidal kinetics (BC) with S. mutans culture. The result for the MIC was the 1:16 dilution (3,125 x 10-2 g/mL), while the CIMA was the 1:128 dilution (3,90625 x 10-3 g/mL) and CB showed bacterial growth 2 hours after the contact of the extract with the bacteria. The conclusion of the present study is that the extract has bacteriostatic and anti-adherent action, however, the bactericidal kinetics needs further studies.